Your browser doesn't support javascript.
loading
Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30.
Regnault, Antoine; Pompilus, Farrah; Ciesluk, Anna; Mazerolle, Flora; Bejar, Rafael; Fram, Robert J; Faller, Douglas V; Marquis, Patrick; Bell, Jill A.
Afiliação
  • Regnault A; Modus Outcomes, 4 Place Amédée Bonnet, 69002, Lyon, France. antoine.regnault@modusoutcomes.com.
  • Pompilus F; Modus Outcomes, Cambridge, MA, USA.
  • Ciesluk A; Modus Outcomes, Cambridge, MA, USA.
  • Mazerolle F; Modus Outcomes, 4 Place Amédée Bonnet, 69002, Lyon, France.
  • Bejar R; Moores Cancer Center, UC San Diego - MDS Center of Excellence, San Diego, CA, USA.
  • Fram RJ; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Faller DV; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
  • Marquis P; Modus Outcomes, Cambridge, MA, USA.
  • Bell JA; Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
J Patient Rep Outcomes ; 5(1): 60, 2021 Jul 20.
Article em En | MEDLINE | ID: mdl-34283303

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Patient Rep Outcomes Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: J Patient Rep Outcomes Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França